Tag | Content |
---|
EnhancerAtlas ID | HS139-22315 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr17:9925240-9926280 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
REST | MA0138.2 | chr17:9925979-9926000 | CTCAGCACCTAGGGCAGCGCC | + | 7.79 | SOX10 | MA0442.2 | chr17:9925570-9925581 | AAAACAAAGAA | + | 6.62 | TCF3 | MA0522.2 | chr17:9926172-9926182 | AACACCTGCT | + | 6.02 |
|
| Number of super-enhancer constituents: 8 | ID | Coordinate | Tissue/cell |
SE_03503 | chr17:9925475-9926730 | Brain_Angular_Gyrus | SE_04219 | chr17:9924144-9926987 | Brain_Anterior_Caudate | SE_05229 | chr17:9921330-9927195 | Brain_Cingulate_Gyrus | SE_06579 | chr17:9921461-9927150 | Brain_Hippocampus_Middle | SE_07470 | chr17:9925281-9930882 | Brain_Hippocampus_Middle_150 | SE_07977 | chr17:9921359-9927400 | Brain_Inferior_Temporal_Lobe | SE_09208 | chr17:9920288-9928585 | CD14 | SE_61661 | chr17:9914051-9963647 | Toledo |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 2 | ID | Chromosome | Start | End |
GH17I010017 | chr17 | 9920718 | 9925317 | GH17I010022 | chr17 | 9925808 | 9925968 |
|
Enhancer Sequence | AGAAATAAAG TCGGCATGGG TGGGGGGTCA GGGGATTAAA ACTGAGGGTT AGGGCCAGGT 60 GCAATGTCTC ACGCTTGTAA TCCTAGCACT TTGGGAGGCC GAGGTGGAAG AATGGCTTGA 120 GCCCAGGAGT TTGAGACCAG CCTGGGCAAC ATAGGAAGAC TCCGTCTGCA AATAATTTTT 180 AAAATTAGCC GGGTGTGGTG GCATACGCCT GTGGTCCCAG CTACTTAGGA GGCTGAGGTG 240 GAAGGATTGC CTGAGCCTAG GAGGTTGTTG CAGTGAGCTG TGATCGCACC ACTGCACTCC 300 AGCCTGGGTG ACAGAGTGAG ACCCTGTCTC AAAACAAAGA ACAAAAAAAT ACAACTACAG 360 GCATGAGTGT TTGATGAAAG AGATTCTAGA ACCAGAGGGG CAAGATGCCA GGTGTCCTCC 420 CCTTGAGTGA AATATTCTAG TTTCTCCTTC AATCAAACAT GGGAAAGCCA TATTGGTACT 480 TATCCAAATA ACTTGGGAGG AAATAGGAAG GATCAAATAT TGACATGGTC AGAAAAGGGG 540 TGCAGGAGAC AGGAACCCAC AGGCACAGCG AAAACAGCCC TCAGGCTCAA ACAGCCTTCA 600 GTGCCAATCC TGCCTGGACC GCTTGACAGC CATGTGACCA CAGGCTACTG ACTCACCAGG 660 CTATTCTCGA ATCTGTGAAA CGAAGGGTGA TAATATGAGC CCAGTTGTGG AAGACGACGG 720 AGAGGGTAAC AATACGTAAC TCAGCACCTA GGGCAGCGCC TGTCCTGAGG GATGCGCAAT 780 GAATGGGGTT TTCCACTGGA AGGGCTTCAC ACAGTCCGTC TACGGCGATA CGGACCTCCA 840 CCCTAGCCTC ACCATCCCTC TGTCTGAAAT GTCAGCATCA ACAGTCACTT CTCTGAGGTT 900 TCTGTTTCCA ATACTACCCG ACTTGAACGG CAAACACCTG CTGGGGAGGT TAACAGCCTG 960 AGAGCTGGCC AGTGCGTTCT GGTGAGAGGG CTGGGCAGTG AGGAGACCAC TCCTTACAGG 1020 AGCTGGAGAG CCAGTGGACC 1040
|